BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 15119959)

  • 1. Serum TNF-alpha in psoriasis after treatment with propylthiouracil, an antithyroid thioureylene.
    Elias AN; Nanda VS; Pandian R
    BMC Dermatol; 2004 Apr; 4():4. PubMed ID: 15119959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD1a expression in psoriatic skin following treatment with propylthiouracil, an antithyroid thioureylene.
    Elias AN; Nanda VS; Barr RJ
    BMC Dermatol; 2003 Jul; 3():3. PubMed ID: 12841851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16 expression in psoriatic lesions following therapy with propylthiouracil, an antithyroid thioureylene.
    Elias AN; Barr RJ; Nanda VS
    Int J Dermatol; 2004 Dec; 43(12):889-92. PubMed ID: 15569009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of PTU on IL-12 and IL-10 in psoriasis.
    Elias AN; Nanda VS; Barr RJ
    J Drugs Dermatol; 2003 Dec; 2(6):645-8. PubMed ID: 14711144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of propylthiouracil and methimazole on serum levels of interleukin-2 receptors in patients with psoriasis.
    Elias AN; Goodman MM; Rohan MK
    Int J Dermatol; 1993 Jul; 32(7):537-40. PubMed ID: 8340196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum ICAM-1 concentrations in patients with psoriasis treated with antithyroid thioureylenes.
    Elias AN; Goodman MM; Rohan MK
    Clin Exp Dermatol; 1993 Nov; 18(6):526-9. PubMed ID: 7902785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of involucrin in psoriatic lesions following therapy with propylthiouracil, an anti-thyroid thioureylene: immunohistochemistry and gene expression analysis.
    Gnanaraj P; Dayalan H; Elango T; Malligarjunan H; Raghavan V; Rao R
    Int J Dermatol; 2015 Mar; 54(3):302-6. PubMed ID: 25267471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced apoptosis in psoriatic plaques after treatment with propylthiouracil.
    Elias AN; Barr RJ
    Eur J Dermatol; 2007; 17(4):353-4. PubMed ID: 17540660
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic efficacy and safety of propylthiouracil in psoriasis: an open-label study.
    Gnanaraj P; Malligarjunan H; Dayalan H; Karthikeyan S; Narasimhan M
    Indian J Dermatol Venereol Leprol; 2011; 77(6):673-6. PubMed ID: 22016273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-thyroid thioureylenes in the treatment of psoriasis.
    Elias AN
    Med Hypotheses; 2004; 62(3):431-7. PubMed ID: 14975517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose oral propylthiouracil in the treatment of plaque psoriasis.
    Elias AR; Barr RJ
    Int J Dermatol; 1995 Jul; 34(7):519-20. PubMed ID: 7591425
    [No Abstract]   [Full Text] [Related]  

  • 12. Antioxidant potential of propylthiouracil in patients with psoriasis.
    Utaş S; Köse K; Yazici C; Akdaş A; Keleştimur F
    Clin Biochem; 2002 May; 35(3):241-6. PubMed ID: 12074833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palmar skin lesions reversed by propylthiouracil therapy.
    Malani AK
    Am J Ther; 2006; 13(4):376-7. PubMed ID: 16858175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of orally administered antithyroid thioureylenes on PCNA and P53 expression in psoriatic lesions.
    Elias AN; Barr RJ; Rohan MK; Dangaran K
    Int J Dermatol; 1995 Apr; 34(4):280-3. PubMed ID: 7790147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled trial of topical propylthiouracil in the treatment of patients with psoriasis.
    Elias AN; Dangaran K; Barr RJ; Rohan MK; Goodman MM
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 1):455-8. PubMed ID: 8077472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antipsoriatic effect of thiamazole is not accompanied either by significant changes in blood lymphocyte subsets nor by serum concentration of TNF-alpha.
    Abe M; Ohnishi K; Hasegawa M; Aoyama K; Tamura A; Kan C; Ishikawa O; Murakami M
    Eur J Dermatol; 2002; 12(4):335-9. PubMed ID: 12095877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propylthiouracil in psoriasis: results of an open trial.
    Elias AN; Goodman MM; Liem WH; Barr RJ
    J Am Acad Dermatol; 1993 Jul; 29(1):78-81. PubMed ID: 8315081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of propylthiouracil on quality of life in psoriasis patients.
    Malligarjunan H; Dayalan H; Gnanaraj P; Elango T; Subramanian S
    Indian J Med Sci; 2011 Aug; 65(8):331-6. PubMed ID: 23442529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of propylthiouracil on adenosine deaminase activity and thyroid function in patients with psoriasis.
    Köse K; Utaş S; Yazici C; Akdaş A; Keleştimur F
    Br J Dermatol; 2001 Jun; 144(6):1121-6. PubMed ID: 11422030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The adverse effects of thioureylene antithyroid drugs (author's transl)].
    Nakashima T; Okamura K; Yoshinari M; Shiroozu A; Nishitani H; Okabe N; Inoue K; Omae T
    Nihon Naibunpi Gakkai Zasshi; 1982 Mar; 58(3):225-33. PubMed ID: 6212270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.